SE0100569D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0100569D0
SE0100569D0 SE0100569A SE0100569A SE0100569D0 SE 0100569 D0 SE0100569 D0 SE 0100569D0 SE 0100569 A SE0100569 A SE 0100569A SE 0100569 A SE0100569 A SE 0100569A SE 0100569 D0 SE0100569 D0 SE 0100569D0
Authority
SE
Sweden
Prior art keywords
new compounds
active compounds
preparation
compounds
new
Prior art date
Application number
SE0100569A
Other languages
English (en)
Inventor
Stefan Berg
Sven Hellberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100569A priority Critical patent/SE0100569D0/sv
Publication of SE0100569D0 publication Critical patent/SE0100569D0/sv
Priority to RU2003121307/04A priority patent/RU2003121307A/ru
Priority to KR10-2003-7010874A priority patent/KR20030084935A/ko
Priority to CNB028052471A priority patent/CN1294131C/zh
Priority to EEP200300400A priority patent/EE200300400A/xx
Priority to HU0303254A priority patent/HUP0303254A2/hu
Priority to MXPA03007320A priority patent/MXPA03007320A/es
Priority to SK1025-2003A priority patent/SK10252003A3/sk
Priority to JP2002565540A priority patent/JP4475869B2/ja
Priority to BR0206935-0A priority patent/BR0206935A/pt
Priority to CZ20032235A priority patent/CZ20032235A3/cs
Priority to US10/468,604 priority patent/US7345050B2/en
Priority to EP02711620A priority patent/EP1373266A2/en
Priority to CA002434648A priority patent/CA2434648A1/en
Priority to IL15678102A priority patent/IL156781A0/xx
Priority to PCT/SE2002/000271 priority patent/WO2002065979A2/en
Priority to PL02363393A priority patent/PL363393A1/xx
Priority to NZ526783A priority patent/NZ526783A/en
Priority to IS6868A priority patent/IS6868A/is
Priority to BG108070A priority patent/BG108070A/bg
Priority to ZA200306171A priority patent/ZA200306171B/xx
Priority to NO20033679A priority patent/NO20033679L/no
Priority to HK05102865A priority patent/HK1070071A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0100569A 2001-02-20 2001-02-20 New compounds SE0100569D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE0100569A SE0100569D0 (sv) 2001-02-20 2001-02-20 New compounds
NZ526783A NZ526783A (en) 2001-02-20 2002-02-18 (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes
CZ20032235A CZ20032235A3 (cs) 2001-02-20 2002-02-18 Nové pyrimidinové sloučeniny
EP02711620A EP1373266A2 (en) 2001-02-20 2002-02-18 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
CNB028052471A CN1294131C (zh) 2001-02-20 2002-02-18 新嘧啶化合物
EEP200300400A EE200300400A (et) 2001-02-20 2002-02-18 Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
HU0303254A HUP0303254A2 (hu) 2001-02-20 2002-02-18 Új pirimidinvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
MXPA03007320A MXPA03007320A (es) 2001-02-20 2002-02-18 Nuevos compuestos de pirimidina.
SK1025-2003A SK10252003A3 (sk) 2001-02-20 2002-02-18 Pyrimidínové zlúčeniny
JP2002565540A JP4475869B2 (ja) 2001-02-20 2002-02-18 新規なピリミジン化合物
BR0206935-0A BR0206935A (pt) 2001-02-20 2002-02-18 Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
RU2003121307/04A RU2003121307A (ru) 2001-02-20 2002-02-18 (диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета
US10/468,604 US7345050B2 (en) 2001-02-20 2002-02-18 Pyrimidine compounds
KR10-2003-7010874A KR20030084935A (ko) 2001-02-20 2002-02-18 Cns 장애 및 당뇨병의 치료에 사용하기 위한(디아졸로-피리디닐)-피리미딘
CA002434648A CA2434648A1 (en) 2001-02-20 2002-02-18 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
IL15678102A IL156781A0 (en) 2001-02-20 2002-02-18 (diazolo-pyridinyl)-pyrimidines for use in teatment of cns disorders and diabetes
PCT/SE2002/000271 WO2002065979A2 (en) 2001-02-20 2002-02-18 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
PL02363393A PL363393A1 (en) 2001-02-20 2002-02-18 New pyrimidine compounds
IS6868A IS6868A (is) 2001-02-20 2003-07-08 Ný pýrimidínefnasambönd
BG108070A BG108070A (bg) 2001-02-20 2003-08-07 Нови пиримидинови съединения
ZA200306171A ZA200306171B (en) 2001-02-20 2003-08-08 (Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes.
NO20033679A NO20033679L (no) 2001-02-20 2003-08-19 Nye pyrimidinforbindelser
HK05102865A HK1070071A1 (en) 2001-02-20 2005-04-06 New pyrimidine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100569A SE0100569D0 (sv) 2001-02-20 2001-02-20 New compounds

Publications (1)

Publication Number Publication Date
SE0100569D0 true SE0100569D0 (sv) 2001-02-20

Family

ID=20283059

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100569A SE0100569D0 (sv) 2001-02-20 2001-02-20 New compounds

Country Status (23)

Country Link
US (1) US7345050B2 (sv)
EP (1) EP1373266A2 (sv)
JP (1) JP4475869B2 (sv)
KR (1) KR20030084935A (sv)
CN (1) CN1294131C (sv)
BG (1) BG108070A (sv)
BR (1) BR0206935A (sv)
CA (1) CA2434648A1 (sv)
CZ (1) CZ20032235A3 (sv)
EE (1) EE200300400A (sv)
HK (1) HK1070071A1 (sv)
HU (1) HUP0303254A2 (sv)
IL (1) IL156781A0 (sv)
IS (1) IS6868A (sv)
MX (1) MXPA03007320A (sv)
NO (1) NO20033679L (sv)
NZ (1) NZ526783A (sv)
PL (1) PL363393A1 (sv)
RU (1) RU2003121307A (sv)
SE (1) SE0100569D0 (sv)
SK (1) SK10252003A3 (sv)
WO (1) WO2002065979A2 (sv)
ZA (1) ZA200306171B (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208479A1 (en) 2002-03-09 2003-09-22 Astrazeneca Ab 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205690D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0226583D0 (en) * 2002-11-14 2002-12-18 Cyclacel Ltd Compounds
GB0311276D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311274D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
TW200528101A (en) 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
WO2006117212A2 (en) 2005-05-04 2006-11-09 Develogen Aktiengesellschaft Use of gsk-3 inhibitors for preventing and treating pancreatic autoimmune disorders
WO2007040436A1 (en) * 2005-10-03 2007-04-12 Astrazeneca Ab Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease
AR058073A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos
RU2428421C2 (ru) * 2005-11-15 2011-09-10 Эррей Байофарма Инк. Производные n4-фенилхиназолин-4-амина и родственные соединения в качестве ингибиторов рецепторной тирозинкиназы типа erbb для лечения гиперпролиферативных заболеваний
TW200811169A (en) * 2006-05-26 2008-03-01 Astrazeneca Ab Chemical compounds
EP2121613A2 (en) * 2007-01-31 2009-11-25 Vertex Pharmaceuticals, Inc. 2-aminopyridine derivatives useful as kinase inhibitors
TWI468417B (zh) 2007-11-30 2015-01-11 Genentech Inc 抗-vegf抗體
EA020114B1 (ru) * 2008-03-24 2014-08-29 Новартис Аг Производные арилсульфонамида в качестве ингибиторов матриксной металлопротеазы
US8344018B2 (en) 2008-07-14 2013-01-01 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
AU2009271003A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors
AU2009271019A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
MX2011001090A (es) 2008-07-28 2011-03-15 Gilead Sciences Inc Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno.
EP2340040B1 (en) 2008-10-22 2019-01-16 F.Hoffmann-La Roche Ag Modulation of axon degeneration
RU2011140238A (ru) 2009-04-15 2013-05-20 Астразенека Аб Имидазол-замещенные пиримидины, полезные в лечении заболеваний, ассоциированных с киназой-3 гликогенсинтазы, таких как болезнь альцгеймера
BRPI1010884A2 (pt) 2009-06-08 2016-03-15 Gilead Sciences Inc composto inibidores hdac de alcanoilamino benzamida anilina
NZ596783A (en) 2009-06-08 2014-01-31 Gilead Sciences Inc Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds
KR102414221B1 (ko) 2020-08-04 2022-06-27 서울시립대학교 산학협력단 열전 소자 어셈블리, 이의 제조 방법, 및 이를 포함하는 열전 모듈

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE29032E (en) * 1969-06-12 1976-11-09 Riker Laboratories, Inc. 3-Benzoylfluoro-methanesulfonanilides
FR2179493A1 (en) * 1972-04-10 1973-11-23 Roussel Uclaf Amino benzhydrols - choleretics anticonvulsants sedatives and barbiturate potentiators
DE3042466A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US5521184A (en) * 1992-04-03 1996-05-28 Ciba-Geigy Corporation Pyrimidine derivatives and processes for the preparation thereof
TW225528B (sv) * 1992-04-03 1994-06-21 Ciba Geigy Ag
GB9523675D0 (en) * 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9701453D0 (en) * 1997-01-24 1997-03-12 Leo Pharm Prod Ltd Aminobenzophenones
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
HK1070071A1 (en) 2005-06-10
JP2004527486A (ja) 2004-09-09
MXPA03007320A (es) 2003-12-04
EP1373266A2 (en) 2004-01-02
CN1294131C (zh) 2007-01-10
HUP0303254A2 (hu) 2004-01-28
WO2002065979A3 (en) 2003-02-20
IL156781A0 (en) 2004-02-08
EE200300400A (et) 2003-12-15
ZA200306171B (en) 2004-11-08
NO20033679D0 (no) 2003-08-19
BR0206935A (pt) 2004-06-29
NZ526783A (en) 2005-04-29
JP4475869B2 (ja) 2010-06-09
CA2434648A1 (en) 2002-08-29
SK10252003A3 (sk) 2004-02-03
US7345050B2 (en) 2008-03-18
IS6868A (is) 2003-07-08
US20040077642A1 (en) 2004-04-22
PL363393A1 (en) 2004-11-15
NO20033679L (no) 2003-08-19
CN1537112A (zh) 2004-10-13
BG108070A (bg) 2004-07-30
RU2003121307A (ru) 2005-02-27
KR20030084935A (ko) 2003-11-01
WO2002065979A2 (en) 2002-08-29
CZ20032235A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
SE0200979D0 (sv) New compounds
SE0100569D0 (sv) New compounds
TW200745111A (en) New compounds
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
TW200510375A (en) New compounds
UY27368A1 (es) Nuevos compuestos
SE0102439D0 (sv) New compounds
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
BR0211473A (pt) Novos compostos
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
TW200606164A (en) New compounds
GB0003154D0 (en) Novel compounds
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
BR0211472A (pt) Novos compostos
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
SE9904508D0 (sv) New compounds
TW200800984A (en) New compounds
SE0102440D0 (sv) New compound
SE0102055D0 (sv) New Compounds
SE0104331D0 (sv) Novel compounds
SE0101322D0 (sv) Novel compounds
ATE253359T1 (de) Antithrombotische mittel
SE0102057D0 (sv) New Salts I
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
ATE286395T1 (de) Antithrombotische mittel